Detalhe da pesquisa
1.
Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines.
Bioorg Med Chem
; 67: 116855, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640378
2.
Establishment and Characterization of a Brca1-/-, p53-/- Mouse Mammary Tumor Cell Line.
Int J Mol Sci
; 21(4)2020 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053991
3.
[Relevance of animal models in the development of compounds targeting multidrug resistant cancer]. / Állatmodellek szerepe a multidrogrezisztens tumorokat célzó kemoterápia fejlesztésében.
Magy Onkol
; 59(4): 338-45, 2015 Dec.
Artigo
em Húngaro
| MEDLINE | ID: mdl-26665195
4.
[Development of novel treatment strategies for drug resistant cancer]. / Új stratégiák fejlesztése a gyógyszerrezisztens daganatok kezeléséhez.
Magy Onkol
; 65(2): 176-187, 2021 Jun 03.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34081765
5.
Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells.
Cells
; 8(11)2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671862
6.
Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer.
J Control Release
; 261: 287-296, 2017 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28700899